Why is Torrent Pharma falling/rising?

As of 08-Aug, Torrent Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 3,572.00, which reflects a decrease of 26.9 points or 0.75%. Despite today's performance showing that the stock outperformed its sector by 0.41%, it has seen a drop in investor participation, with delivery volume falling by 15.9% compared to the 5-day average. Over the past week, the stock has decreased by 2.78%, although it has shown positive returns over the longer term, including a 7.66% increase over the past month and a substantial 129.38% rise over the last three years. The company has maintained strong fundamentals, evidenced by high management efficiency, a low Debt to EBITDA ratio, and consistent positive results over the last eight quarters.
In the broader market context, Torrent Pharmaceuticals has outperformed the Sensex, which has declined by 0.92% over the past week. This indicates that while the stock is facing short-term challenges, it has been able to deliver consistent returns over the longer term, outperforming the benchmark in various time frames. The high institutional holdings at 24.75% suggest that knowledgeable investors continue to support the stock, reflecting confidence in its fundamentals despite the recent price drop. Overall, while the stock is currently facing downward pressure, its strong operational performance and historical returns provide a foundation for potential recovery.